电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

BCDIN3D 抗体 (AA 1-292)

BCDIN3D 适用: 人 ELISA 宿主: 兔 Polyclonal unconjugated
产品编号 ABIN7164145
发货至: 中国
  • 抗原 See all BCDIN3D 抗体
    BCDIN3D (BCDIN3 Domain Containing (BCDIN3D))
    抗原表位
    • 5
    • 1
    AA 1-292
    适用
    • 7
    • 1
    宿主
    • 8
    克隆类型
    • 8
    多克隆
    标记
    • 4
    • 2
    • 1
    • 1
    This BCDIN3D antibody is un-conjugated
    应用范围
    • 4
    • 3
    • 1
    ELISA
    交叉反应
    纯化方法
    >95%, Protein G purified
    免疫原
    Recombinant Human Pre-miRNA 5\'-monophosphate methyltransferase protein (1-292AA)
    亚型
    IgG
    Top Product
    Discover our top product BCDIN3D Primary Antibody
  • 应用备注
    Optimal working dilution should be determined by the investigator.
    限制
    仅限研究用
  • 状态
    Liquid
    缓冲液
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    储存液
    ProClin
    注意事项
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    -20 °C,-80 °C
    储存方法
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 抗原
    BCDIN3D (BCDIN3 Domain Containing (BCDIN3D))
    别名
    BCDIN3D (BCDIN3D 产品)
    别名
    4930556P03Rik antibody, AV138748 antibody, BCDIN3 domain containing RNA methyltransferase antibody, BCDIN3 domain containing antibody, BCDIN3D antibody, Bcdin3d antibody
    背景

    Background: O-methyltransferase that specifically dimethylates the 5\' monophosphate of pre-miRNAs, acting as a negative regulator of miRNA processing. The 5\' monophosphate of pre-miRNAs is recognized by DICER1 and is required for pre-miRNAs processing: methylation at this position reduces the processing of pre-miRNAs by DICER1. Able to mediate methylation of pre-miR-145, as well as other pre-miRNAs.

    Aliases: BCDIN3 domain containing antibody, BCDIN3 domain-containing protein antibody, BCDIN3D antibody, BN3D2_HUMAN antibody, Probable methyltransferase BCDIN3D antibody

    UniProt
    Q7Z5W3
You are here: